Prescription drug · ANDA
Acd A NDC 14537-810
citric acid monohydrate, dextrose monohydrate, and trisodium citrate dihydrate · Citric acid monohydrate .8 g/100mL + 2 more ingredients · Injection, Solution · Intravenous · Terumo BCT, Ltd
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 14537-810-12 | 14537081012 | 12 BAG in 1 CARTON (14537-810-12) / 750 mL in 1 BAG (14537-810-75)Marketed from Jun 1, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Acd ASuffix: A
- Generic name (nonproprietary)
- citric acid monohydrate, dextrose monohydrate, and trisodium citrate dihydrate
- Active ingredients
- Citric acid monohydrate — .8 g/100mLDextrose monohydrate — 2.45 g/100mLTrisodium citrate dihydrate — 2.2 g/100mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Terumo BCT, Ltd
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application BA 010228
- Marketing start
- Listing expires
- Other FDA classes
- Acidifying Activity (Mechanism)Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)Decreased Coagulation Factor Activity (Physiologic effect)
- Identifiers
- Product ID 14537-810_7ca66901-24d8-4bdb-995d-c538cb238306SPL ID 7ca66901-24d8-4bdb-995d-c538cb238306SPL set ID 8e255bc7-a120-460a-a32d-43931f8115deUNII 2968PHW8QP, LX22YL083G, B22547B95K
- Pharmacologic class
- Anti-coagulant; Calculi Dissolution Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N414537081012followed by a unit qualifier and the quantityPackage 14537-0810-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Anticoagulant Citrate Dextrose Solution USP (ACD) Solution A is an anticoagulant for blood collection for use only with apheresis devices. [See Dosage and Administration (2) .] Anticoagulant Citrate Dextrose Solution USP (ACD) Solution A is an anticoagulant for blood collection for use only with apheresis devices. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under BA 010228
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Acd Acitric acid monohydrate, dextrose monohydrate, and trisodium citrate dihydrate | Citric acid monohydrate .8 g/100mL + 2 more ingredients | Injection, SolutionIntravenous | Terumo BCT, Ltd. | 14537-817 |
| Acd Adextrose monohydrate, sodium citrate, and citric acid monohydrate | Dextrose monohydrate 2.45 g/100mL + 2 more ingredients | Injection, SolutionIntravenous | Terumo BCT Ltd | 14537-967 |